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ABSTRACT 
Objective: The objective of the present study was to determine the effect of streptozotocin (STZ) induced diabetes type 1 on activity of acetyl-
cholinesterase (AChE) in rat brain and on the brain antioxidant status and also that whether supplementation with the aqueous extract of Vitex 
negundo (AEVN) ameliorates neural degeneration caused by hyperglycemia induced oxidative stress in experimental diabetes. 
Methods: Male albino rats weighing 180-200g were made diabetic by the single administration of STZ (45 mg/kg body weight) intraperitoneally. 
AEVN was administered orally through feeding cannula at a dose of 150 mg/kg body weight daily to STZ-induced diabetic rats for 60 days. On 61st
Results: In the result it is observed that STZ-diabetes caused significant elevation in fasting blood glucose, AChE activity and lipid peroxidase (LPO) 
level. Whereas activity level of the protective antioxidant enzyme, catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) 
exhibited significant decline in STZ-diabetes. Supplementation with AEVN attests significant anti-diabetic and antioxidant potential of it as a 
prominent decrease in fasting blood glucose level and AChE activity was observed. Similarly, the levels of the protective antioxidant enzymes like 
SOD, CAT and GSH were increased along with the decrease in the level of oxidant enzyme LPO was observed.  
 
day the rats were sacrificed by cervical dislocation and the effects of the AEVN on fasting blood glucose level. AChE activity and on levels of various 
oxidant and antioxidant enzyme activity in the brain were appraised.  
Conclusion: The study emphasizes the involvement of diabetes with neural degeneration and point towards the potential beneficial role of AEVN as 
an adjuvant therapy to conventional anti-hyperglycemic regimens for the prevention and treatment of diabetic encephalopathy. 
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INTRODUCTION 
Diabetes mellitus is a very common and heterogenous metabolic 
disorder, which is known to cause a variety of complications such as 
renal failure, blindness, limb amputation, neurological 
complications, vascular complications of coronary artery disease, 
cerebrovascular disease and/or premature death [1,2,] affecting 5% 
of the world’s population [3].The World Health Organization (WHO) 
estimates that more than 300 million people will contract diabetes 
by the year 2025 and the global cost of treating this disease and its 
complications could reach US$1 trillion annually [4] and that it is 
likely to double by 2030, with India, China and United States 
predicted to have the largest number of affected individuals[5,6]. 
Diabetes mellitus is known to have potential to cause cerebral injury 
[7,8]. In diabetic neuropathy, it is known that cerebral uptake of 
glucose is significantly affected [9-11] and the brain suffers from 
hypoglycaemic and hyperglycaemic episodes[12].Diabetes-induced 
hyperglycemia is known to increase the extent of neurological 
disorders due to inhibition of enzymatic activities connected to 
neurotransmission [13,14] in the central nervous system (CNS) of 
mammals and the changes observed have been attributed to 
alterations occurring in the levels of RNA and proteins [15]. 
Although different types of oral hypoglycemic agents are available 
along with insulin for the treatment of diabetes mellitus, none offers 
complete glycemic control [16]. Traditional plant medicines are used 
throughout the world for a range of diabetic presentations. 
Therefore, an investigation of such agents from traditional medicinal 
plants has become particularly important. India has a rich history of 
using various potent herbs and herbal components for treating 
diabetes. Many Indian plants have previously been investigated for 
their beneficial use in different types of diabetes [17]. To date, there 
are many hundreds of herbs and traditional herbal formulas 
reported to have been used for the treatment of diabetes mellitus 
[18].Although the ischemic manifestations and cerebral disorders in 
diabetes have been documented, the pathogenesis of diabetes-
induced cerebral dysfunction still remains to be elucidated. Vitex 
negundo Linn. (Family: Verbenaceae) (VN) is commonly known as 
five leaved Chaste Tree in English and Nirgundi in Hindi [19] VN is 
large, aromatic, shrub or a small, slender tree with an irregular trunk 
growing up to 4.5 m in height. Its stem and branches are covered 
with thin, grey bark, which becomes almost black and scaly when 
old. It occurs wild in most parts of India near moist places [20]. 
Although all parts VN are used as medicine in the indigenous system 
of medicine, the leaves are the most potent for medicinal use [21]. It 
has been employed in Indian traditional medicinal system for the 
treatment of various ailments including brain tonic and to improve 
memory [22,23]. The effectiveness of VN has been scientifically 
reported for various activities such as anti-inflammatory [24]; 
gastroprotective [25]; anti-cancer [21]; antioxidant [26,27]; CNS 
depressant [28]; anticonvulsant [29]; etc. VN leaves contains 
monoterpenoids iridoids (2-p-hydroxybenzoyl mussaenosidic; 
nishindaside; negundoside), triterpenoids (betulinic acid; ursolic 
acid), flavonoids (gardenin A; gardenin B; corymbosin; vitexicarpin; 
5-hydroxy-3,6,7,3,4-penta-metoxyflavone; 3,5-dihydroxy-6,7,3,4 
tetramethoxyflavanol), phenolic acid (p-hydroxybenzoic acid; 3,4-
dihydroxybenzoic acid), and essential oil (sabinene, 4-terpineol, β-
caryophyllene, and viridiflorol) [20].
The current study was designed to explore the antidiabetic, 
neurochemical-antioxidant and cognition protective activities of 
aqueous extract of Vitex negundo (AEVN) leaves in an experimental 
rat model for Strptozotocin (STZ) induced diabetes. This study may 
be a holistic approach towards developing a novel drug from Indian 
folklore for diabetic encephalopathy. 
  
MATERIALS AND METHODS 
Animals 
Male albino rats of body weight 180–200 g were used and were 
housed in groups of 3-4 in standard polypropylene cages with wire 
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mesh top at standard environmental condition of temperature 
(25±2)℃ and relative humidity of 45%-55% under 10 h: 14 h light: 
dark cycle in the animal house of Department of Bioscience, 
Barkatullah University, Bhopal. Animals had free access to standard 
pellet rodent diet and water was provided ad libitum. Experiments 
and maintenance were carried out in accordance with guidelines of 
the Committee for the Purpose of Supervision and Control of 
Experiments on Animals (CPCSEA), India and the study was 
approved by the ethical committee (500/a/CPCSEA/006/2009). 
Drugs and chemicals 
Streptozotocin [N-(Methylnitrosocarbamoyl)-α-D-glucosamine], 
(Streptozotocin®, Hi-Media, India); insulin (Human Actrapid®
Plant material 
, Novo-
Nordisk, India); and other chemicals of analytical grade were 
procured from the chemical traders and medical shops of Bhopal, 
India.  
Commercially available (AEVN) aqueous extract of Vitex negundo 
(Amruta Herbals Pvt. Ltd.) was dissolved in water (15 mg/100 µl) and 
was given orally through gavage to rat at a dose of 150 mg/kg bwt. 
Induction of diabetes mellitus 
The rats were fasted for 12 h (overnight) and diabetes was induced 
by a single intraperitoneal administration of freshly prepared 
streptozotocin which were dissolved in 0.1M Na-Citrate buffer of pH 
4.5. Prepared STZ at a dose of 45 mg/kg body weight were use for 
the induction. Diabetes was confirmed after second day of 
administration by polydipsia, polyuria and by measuring fasting 
blood glucose concentration, using commercial glucose strip (Accu-
Chek®
Experimental design 
 glucometer). Only animals with fasting blood glucose level of 
200 mg/dL and above was considered diabetic and used for the 
experiment. 
Twenty four male albino rats were randomly divided into four groups 
of six each. Group I consisted of control animals; Group II served as 
diabetic control rats and it received single i. .p. administration of 
Streptozotocin (45mg/kg bwt.); Group III consisted of Streptozotocin 
(45 mg/kg bwt., i. .p.) induced diabetic rats and treated with AEVN 
(150 mg/kg bwt., oral gavage) daily for 60 days; Group IV consisted of 
Streptozotocin (45 mg/kg bwt. i. .p.) induced diabetic rats and treated 
with Insulin (4U, i. .m.) Daily for 60 days.  
Biochemical estimations of brain 
On 61
i. Supernatant preparation 
st day the fasting blood glucose of animals were checked by Accu-
Chek® Active glucometer and sacrificed by cervical dislocation and 
brain of individual animal was carefully isolated, placed on the 
petridish, over ice, and weighed. Whole brain samples were rinsed 
with ice cold normal saline. A 20 mg tissue/ml homogenate of brain 
samples were prepared by homogenizing in chilled phosphate buffer 
(pH 7.4). The homogenates were centrifuged at 800 g for 5 minutes at 
4°C to separate the nuclear debris. The supernatant thus obtained was 
centrifuged at 10,500 g for 20 minutes at 4°C to get the supernatant. 
Supernatant was collected from individual animal from all groups and 
subjected to the estimation of AChE level, lipid peroxidation (LPO), 
catalase activity (CAT) and reduced glutathione (GSH). 
ii. Estimation of Brain AChE level  
Cholinergic dysfunction was assessed by measuring AChE levels in 
whole brain according to the method of Ellman et al. (1961) 
[30].Briefly, 0.4 ml supernatant was added to a cuvette containing 
2.6 ml of sodium phosphate buffer (0.1 M, pH 
R = 5.74 (10
7.2) to which a 100 µl 
of Ellaman’s reagent (0.5 mM, 19.8 mg DTNB and 0.1 M sodium 
phosphate, pH 7.2 to make 100 ml) was added and absorbance was 
measured in spectrophotometer at 412 nm till the increasing 
absorbance become stable. This stable absorbance was then set to 
zero and 20 µl of acetylthiocholine iodide (substrate) was added and 
changes in absorbance per minute were recorded for 10 minutes. 
The change in absorbance per minutes was calculated. The rate was 
calculated by using following formula and AChE activity was 
measured as µM/l/min/g tissue.  
-4
Where, R is rate, in moles substrate hydrolyzed per minutes per g of 
tissue; A is change in absorbance per minutes; Co is the original 
concentration of tissue i. .e. 20 mg/ml. 
) × A / Co  
iii. Estimation of Brain Lipid Peroxidation (LPO) 
Lipid peroxidation was measured by the method of Okhawa et al. 
(1979) [31]. Briefly, to 0.2 ml of test sample, 0.2 ml of SDS, 1.5 ml of 
acetic acid and 1.5 ml of TBA were added. The mixture was made up 
to 4 ml with water and then heated in a water bath at 95°C for 60 
minutes. After cooling, 1 ml of water and 5 ml of n-butanol/pyridine 
mixture were added and shaken vigourously. After centrifugation at 
4000 rpm for 10 minutes, the organic layer was taken and its 
absorbance was read at 532 nm. The level of lipid peroxides was 
expressed as nmoles of MDA released/ mg protein and was 
calculated using a molar extinction coefficient of 1.56×105 M/cm.  
iv. Estimation of Brain Superoxide Dismutase (SOD) 
Superoxide dismutase was estimated by the method described by 
Kakkar et al. (1984) [32]. Briefly, 0.5 ml of plasma was diluted to 1.0 
ml with ice cold water, followed by 2.5 ml ethanol and 1.5 ml 
chloroform (chilled reagent). The mixture was shaken for 60 
seconds at 4°C and then centrifuged. The enzyme activity in the 
supernatant was determined as follows. The assay mixture 
contained 1.2 ml of sodium pyrophosphate buffer, 0.1 ml of 
phenazine methosulphate and 0.3 ml of nitro-blue tetrazolium 
(NBT) and approximately diluted enzyme preparation in a total 
volume of 3 ml. The reaction was started by the addition of 0.2 ml 
NADH. After incubation at 30°C for 90 seconds, the reaction was 
stopped by the addition of 1 ml glacial acetic acid. The reaction 
mixture was stirred vigorously and shaken with 4 ml n-butanol. The 
mixture was allowed to stand for 10 minutes, centrifuged and 
butanol layer was separated. The colour intensity of the chromogen 
in the butanol layer was measured in a spectrophotometer at 520 
nm. A system devoid of enzyme served as control. One unit of 
enzyme activity is defined as the enzyme concentration, which gives 
50% inhibition of NBT reduction in one minute under assay 
conditions. SOD activity was expressed as U/mg of protein. 
v. Estimation of Brain Reduced Glutathione (GSH) 
Reduced glutathione (GSH) is estimated by methods based on 
principles of methods of Moron et al. (1979) [33]. 0.5 ml of 
supernatant was taken in a test tube and 2 ml of distilled water was 
added, mixed well. Then it was centrifuged for 5 min at 5000 rpm. 
0.5 ml of supernatant was taken, to which 0.5 ml of TCA (5%) was 
added and then centrifuged for 10 min at 10,000 rpm. 0.5 ml of 
supernatant was taken to which 2.5 ml of phosphate buffer (pH 8) 
was added. To this 1 ml DTNB was added. This solution was inverted 
for 3 times to mix. The absorbance was read on spectrophotometer 
at 412 nm within 4 min. of preparing the mixtures. Standard graph 
of reduced glutathione GSH concentrations was plotted. 
Determination of reduced glutathione GSH concentration was done 
from the graph and expressed as µg/mg protein. 
vi. Estimation of Brain Catalase (CAT) 
Catalase activity was measured by the method of Aebi (1979) [34]. 
0.1 ml of supernatant was added to cuvette containing 1.9 ml of 50 
mM phosphate buffer (pH 7.0). Reaction was started by the addition 
of 1.0 ml of freshly prepared 30 mM H2O2. The rate of 
decomposition of H2O2 was measured spectrophotometrically from 
changes in absorbance at 240 nm. Activity of catalase was expressed 
as µmoles of H2O2 
Statistical Analysis 
Results were expressed as mean ± S. .E. .M. The inter group variation 
was measured by one way analysis of variance (ANOVA) followed by 
Tukey’s test. Statistical significance was considered at P < 0.05. The 
statistical analysis was done using the Sigma Stat Statistical Software 
version 3.5. 
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After induction of diabetes on the 61st day, the fasting blood glucose 
level was highly elevated in the diabetic animals (P＜0.001). After 
treatment with AEVN leaves the fasting blood glucose level was 
significantly decreased compared to that of the diabetic controls 
(P<0.001). And (4U/day) insulin significantly decreased the serum 
glucose level (P<0.001) (Table 1). 
 
Table 1: Effect of AEVN Leaves on Fasting Blood Glucose Level Of 
STZ-Diabetic Rats. 
utilised / second. 
Groups n Fasting Blood Glucose (mg/dl) 
Initial (1st Final (61 day) st day) 
Control 6 82.0±1.7 82.0±1.9 
Diabetic Control 6 218.0±1.8 325.0±2.3*** 
Diabetic+AEVN 
*** 
6 218.0±1.3 98.0±1.0*** 
Diabetic+Insulin 
NS,∆∆∆ 
6 221.0±1.8 85.0±1.8*** NS,∆∆∆ 
± = Standard Error of Mean (SEM) of 6 Animals. NS = Non Significant, 
*=P< 0.05, **=P<0.01, ***=P<0.001 vs Control group, △=P ＜
0.05, △△=P<0.01, △△△=P<0.001 vs 
Acetylcholinesterase activity was significantly increased in diabetic 
controls when compared with the normal controls (P<0.001). After 
treatment with AEVN leaves showed a significant decrease in 
acetylcholinesterase activity in diabetic animals (P<0.001), and 200 
mg/kg of piracetam-treated group showed a significant decrease in 
acetylcholinesterase activity (P<0.01), whereas (4U/day) insulin-
treated group did not show the significant effect in this regard, 
(Table 2). 
Diabetic control group. 
 
 
Table 2: Effect of AEVN Leaves on AChE Level in Brain of STZ-
Diabetic rats 
Groups n AChE activity 
(µM/min/l/g tissue) 
Control 6 3.67±0.47 







± = Standard Error of Mean (SEM) of 6 Animals. NS = Non Significant, 
*=P 0.05, **=P<0.01, ***=P<0.001 vs Control group, △=P ＜
0.05, △△=P<0.01, △△△=P<0.001 vs 
 
Diabetic control group. 
The results showed a significant increase in LPO level (P<0.01), and 
significant decreases in SOD (P<0.01), CAT (P<0.001) and Reduced 
GSH (P<0.01) levels in the diabetic controls compared to those of the 
normal controls. After treatment with AEVN leaves STZ-diabetic rats 
showed a significant decrease in LPO level and improvement in 
SOD,CAT and reduced GSH levels (P<0.001). After treatment with 
(4U/day) insulin, it showed a significant reduction (P<0.001) in LPO 
level while a significant increase in SOD level in the diabetic animals 
(P<0.001) (Table 3). 
 
Table 3: Effect of AEVN Leaves on LPO, SOD, CAT and Reduced GSH Levels in Brain of STZ-Diabetic Rats. 
Groups n LPO 






(µmoles of H2O2 utilised / second) 
Control 6 1.49±0.02 7.75±0.38 22.24±0.7 3.12±0.29 
Diabetic Control 6 3.65±0.02 5.17±0.27** 17.13±0.84** 0.86±0.05** 
Diabetic+AEVN 
*** 
6 1.58±0.01 6.90±0.22NS,∆∆∆ 20.67±0.78NS,∆∆∆ 2.75±0.20NS,∆∆∆ 
Diabetic+Insulin 
NS,∆∆∆ 
6 1.55±0.01 7.51±0.56NS,∆∆∆ 20.01±0.90NS,∆∆∆ 1.98±0.11NS,∆∆∆ *,∆∆∆ 
± = Standard Error of Mean (SEM) of 6 Animals. NS = Non Significant, *=P< 0.05, **=P<0.01, ***=P<0.001 vs Control group, △=P＜
0.05, △△=P<0.01, △△△=P<0.001 vs 
 
Diabetic control group. 
DISCUSSION 
This research work is one of a series of studies showing that chronic 
hyperglycemia causes an imbalance in the oxidative status of the 
nervous tissue and that the resulting free radicals damage the brain 
through a peroxidative mechanism. The STZ diabetic rat serves as an 
excellent model to study the molecular, cellular and morphological 
changes in the brain induced by stress during diabetes[35]. Under 
normal conditions, the generation of free radicals or of active species 
in the brain, as in other tissues, is maintained at extremely low 
levels[36]. Diabetes also contributes to cerebrovascular 
complications, reductions in cerebral blood flow, disruption of the 
blood brain barrier and cerebral edema [37]. All of these 
neurochemical and neurophysiological changes ultimately 
contribute to the long-term complications associated with diabetes, 
including morphological abnormalities, cognitive impairments and 
increased vulnerability to pathophysiological event [38]. Currently 
available drugs for the treatment of Diabetes mellitus have a number 
of limitations, such as adverse effects and a high rate of secondary 
failure [39].As there is a growing trend towards using natural 
remedies adjunct to conventional therapy, traditionally used plants 
might provide a useful source of new hypoglycemic compounds [40]. 
A number of plants have been reported to possess hypoglycemic 
effects and the possible mechanism suggested for such hypoglycemic 
actions could be through the increased insulin secretion from β-cells 
of islets of Langerhans or its release from bound insulin. 
Alternatively such hypoglycemic effects of plant extracts could also 
be because of their insulin-like actions [41,42] Similar mechanisms 
may be considered responsible for the hypoglycemic action shown 
by AEVN in diabetic rats. 
In diabetic condition, a significant rise in acetylcholinesterase 
activity in the brain of the diabetic animals is observed, as this 
enzyme hydrolyses acetylcholine present in the brain and results in 
cognitive decline [43]. AChE enzyme is essential in maintaining the 
normal function of the nervous system, since it rapidly terminates 
the action of ACh released into the synapse. Cholinergic 
interneurons in the striatum are even richer source of AChE [44]. 
One of the treatment strategies to enhance cholinergic functions is 
the use of AChE inhibitors that increase the availability of ACh in 
central cholinergic synapses [44,45]. Sixty days treatment with 
AEVN leaves attenuated the increase in acetylcholinesterase activity 
in the brain of the diabetic animals. This decrease in 
acetylcholinesterase activity is may be due to flavonoids content of 
the extract [46].  
Lipid peroxidation is one of the characteristic features of chronic 
diabetes and lipid peroxidation mediated tissue damage has been 
observed in diabetic conditions [47]. Hyperglycemia generates 
reactive oxygen species (ROS), which in turn cause lipid 
peroxidation and membrane damage [48]. The increased lipid 
peroxidation during diabetes, as found in the present study may be 
due to the inefficient anti-oxidant system prevalent in diabetes. The 
elevated lipid peroxidation is responsible for the formation of lipid 
hydroperoxides in membrane and would result in damage of the 
membrane structure and inactivation of membrane- bound enzymes. 
The accumulation of lipid peroxides adds hydrophilic moieties into 
the hydrophobic phase and thereby brings about changes in the 
membrane permeability and cell functions [49]. Diabetes-induced 
oxidative damage [50] is responsible for the changes occurring in 
activities of membrane-bound enzymes of significance in neuronal 
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activity. Earlier studies have also reported an increase in lipid 
peroxidation leading to impaired neuronal activity in diabetes 
mellitus [51]. Treatment with AEVN leaves significantly lowered LPO 
in the brain of diabetic rats and simulated the anti-diabetic response 
of insulin treatments.  
Glutathione (GSH), a tripeptide normally present in high 
concentrations intracellularly constitutes the major reducing 
capacity of the cytoplasm [52] and protects the cellular system 
against the toxic effects of lipid peroxidation [53].The diabetic 
animals in the present study registered lowered levels of GSH 
reflecting its increased utilization owing to oxidative stress while, a 
significant elevation of GSH levels in AEVN leaves administered to 
diabetic rats coincided with a significant decline in lipid 
peroxidation. It appears that the effect of AEVN leaves on GSH could 
be at two levels – either through increasing the biosynthesis of GSH 
or by inhibiting its utilization by reducing oxidative stress. 
The antioxidant enzymes SOD and CAT play an important role in 
reducing cellular stress. SOD scavenges the superoxide radical by 
converting it to hydrogen peroxide and molecular oxygen [54], while 
CAT brings about the reduction of hydrogen peroxides and protects 
higher tissues from the highly reactive hydroxyl radicals [55]. In the 
present investigation both these enzymes registered low levels of 
activity in diabetic controls indicating diabetes-induced stress. Such 
a decline in these enzyme activities has also been reported earlier 
[56,57]. The AEVN leaves when administered to the diabetic animals 
improved both SOD and CAT activities substantially, reflecting the 
antioxidant potency of VN. The effects of AEVN leaves on 
antioxidants (GSH, SOD, CAT and LPO) were found to be better than 
those of insulin administered diabetic animals. Our data confirmed 
that type 1 diabetes is an oxidative state that causes a statistically 
significant decrease of the rat brain total antioxidant status.  
Hyperglycemia is known to induce a disruption of the mitochondrial 
membrane potential and an increase in the formation of reactive 
oxygen species (ROS) [58]. This diabetes-induced oxidative stress 
has been demonstrated to play an important role in the occurring 
brain damage due to diabetes, in both humans and animals suffering 
from the disease [59]. This damage is mainly caused by: increased 
ROS formation, increased malondialdehyde levels, as well as 
decreased catalase and superoxide dismutase activities [60,61]. Our 
data reveal that AEVN leaves administration can be a protective 
treatment against the diabetes-induced oxidative stress occurring in 
the rat brain, since it can efficiently reverse the total antioxidant 
status of diabetic rat brain into those of the control group.  
CONCLUSION 
In conclusion, diabetes-induced hyperglycaemic injury accounts for 
the oxidative damage and down-regulation of the activities of 
antioxidant and membrane-bound enzymes of functional 
significance leading to impaired neuronal function. Our study shows 
that AEVN leaves intake is effective in up-regulating the antioxidant 
defence mechanism by attenuating the oxidative stress. Changes in 
the cholinergic system, suggest that AEVN leaves have 
neuroprotective effect in STZ-induced diabetes. Thus, treatment 
with AEVN leaves for ameliorating the cognitive decline, cholinergic 
dysfunction, and oxidative stress in the diabetic animals can 
innovate the clinical application in treating neuronal deficit in the 
diabetic patients. 
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